Trials / Completed
CompletedNCT05373082
Identification of Modifying Factors in Hereditary Spastic Paraplegia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 311 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A first questionnaire - MODIFSPA conducted in 2014 - identified several environmental factors influencing spasticity in HSP: cold, fatigue, and especially physical activity. In order to improve the care of patients with HSP, The investigator team are looking to deepen the knowledge on physical exercises relieving spasticity as well as to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders. A new questionnaire was therefore created to collect additional information to optimize the care of patients with HSP.
Detailed description
The only common symptom of hereditary spastic paraplegia (HSP) is the presence of spasticity in the lower limbs, associated with a great clinical and genetic heterogeneity. A first MODIFSPA study carried out by the team identified environmental factors influencing spasticity: stress, fatigue, physical activity. In this first study, only spasticity was studied but several symptoms appeared to require medical management according to the patients: fatigue and vesico-sphincter disorders. Following this first study, MODIFSPA2 aims to deepen our knowledge of HSP, via the expertise of patients, to propose a care in adequacy with their needs/demands. Validated scales are included in the questionnaire to evaluate the frequency and intensity of the symptoms most reported by patients (fatigue, pain and mood disorders). Questions are asked to better know the frequency of symptoms requiring additional medical care: fatigue and vesico-sphincter disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire completion | Questionnaire to be completed by patients |
Timeline
- Start date
- 2022-10-04
- Primary completion
- 2023-10-03
- Completion
- 2023-10-03
- First posted
- 2022-05-13
- Last updated
- 2023-10-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05373082. Inclusion in this directory is not an endorsement.